Rebeca Perez de Diego

Fundación para la Investigación Biomédica del Hospital Universitario La Paz

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (9)

Roberto Alonso Fernandez

Instituto de Investigación Sanitaria Gregorio Marañón

SPAIN

View details

Kirsten Dummer

Associate Professor

University of California, San Diego

UNITED STATES

View details

Silvia SÁNCHEZ-RAMÓN

Head of Department

Hospital Clínico San Carlos

SPAIN

View details

Michael CARTER

King’s College London

UNITED KINGDOM

View details

Pedro Madrigal

EMBL-European Bioinformatics Institute

UNITED KINGDOM

View details

Ruud Gerard Nijman

Senior clinical lecturer

Imperial College London

UNITED KINGDOM

View details

CHARY LOPEZ-PEDRERA

Head of Research

SPAIN

View details

Carlos Rodríguez-Gallego

Associated Professor

Universidad Fernando Pessoa Canarias

SPAIN

View details

ADRIAN HAYDAY

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rebeca Perez de Diego

Research Interests

Explore related searches

Contact this professor

Articles (10)

Serum adipsin levels in rheumatic diseases: defining its role in disease activity and progression in rheumatoid arthritis and axial spondyloarthritis.

Phosphoinositide-3-kinase δ as an immune check-pathway in cancer Immunology. Therapeutic prospects.

IEIVariantFilter: a bioinformatics tool to speed up genetic diagnosis of inborn errors of immunity patients.

Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis?

Immunoglobulin G4-related disease and B-cell malignancy due to an IKZF1 gain-of-function variant

An Exploratory Approach of Clinically Useful Biomarkers of Cvid by Logistic Regression.

Heterozygous <i>BTNL8</i> variants in individuals with multisystem inflammatory syndrome in children (MIS-C)

The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19.

Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients.

Lack of Specific Immune Response after Five Doses of mRNA SARS-CoV-2 Vaccine in a Patient with CD4<sup>+</sup> T-Cell Lymphopenia but Preserved Responses to CMV

Collaborators (9)

Roberto Alonso Fernandez

Kirsten Dummer

Silvia SÁNCHEZ-RAMÓN

Michael CARTER

Pedro Madrigal

Ruud Gerard Nijman

CHARY LOPEZ-PEDRERA

Carlos Rodríguez-Gallego

ADRIAN HAYDAY

Make your next move.